161 related articles for article (PubMed ID: 32042082)
21. Molecular cytogenetics in haematological malignancy: current technology and future prospects.
Kearney L; Horsley SW
Chromosoma; 2005 Sep; 114(4):286-94. PubMed ID: 16003502
[TBL] [Abstract][Full Text] [Related]
22. [Fluorescence in situ hybridization in hematology].
Milosević I; Popović S; Urosević I
Vojnosanit Pregl; 2012 Nov; 69(11):986-93. PubMed ID: 23311251
[No Abstract] [Full Text] [Related]
23. t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.
Bernués M; González T; Corchete LA; Santos S; Durán MA; López-Andrade B; Riso LL; Martínez-Serra J; Ramos R; Iglesias J; Royo I; Rosell J
Cancer Genet; 2022 Jun; 264-265():60-65. PubMed ID: 35397254
[TBL] [Abstract][Full Text] [Related]
24. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
25. [Genetic methods in diagnosis of hematooncological disorders].
Macheta A; Chocholska S; Podhorecka M
Postepy Hig Med Dosw (Online); 2015 Apr; 69():475-87. PubMed ID: 25897109
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
27. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
28. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.
Romana SP; Radford-Weiss I; Ben Abdelali R; Schluth C; Petit A; Dastugue N; Talmant P; Bilhou-Nabera C; Mugneret F; Lafage-Pochitaloff M; Mozziconacci MJ; Andrieu J; Lai JL; Terre C; Rack K; Cornillet-Lefebvre P; Luquet I; Nadal N; Nguyen-Khac F; Perot C; Van den Akker J; Fert-Ferrer S; Cabrol C; Charrin C; Tigaud I; Poirel H; Vekemans M; Bernard OA; Berger R;
Leukemia; 2006 Apr; 20(4):696-706. PubMed ID: 16467868
[TBL] [Abstract][Full Text] [Related]
29. [Genetic analysis and immunophenotyping in the diagnosis of hematological disease].
Hergersberg M; Röthlisberger B; Heijnen IA; Huber AR
Ther Umsch; 2004 Feb; 61(2):83-91. PubMed ID: 15018391
[TBL] [Abstract][Full Text] [Related]
30. [How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Raus N; Karam M; Chebel R; Dantin C; Pereira M; Wallart A; Yakoub-Agha I; Srour M
Bull Cancer; 2020 Jan; 107(1S):S52-S61. PubMed ID: 31615645
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Lefebvre C; Callet-Bauchu E; Chapiro E; Nadal N; Penther D; Poirel HA
Ann Biol Clin (Paris); 2016 Oct; 74(5):568-587. PubMed ID: 27707672
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic studies in hematologic malignancies: an overview.
Swansbury J
Methods Mol Biol; 2003; 220():9-22. PubMed ID: 12744203
[No Abstract] [Full Text] [Related]
33. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
Kakazu N; Abe T
Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
[No Abstract] [Full Text] [Related]
34. [Recommendations for the cytogenetic management of myelodysplastic syndrome by the French Group fo Cytogenetic Hematology].
Groupe Français de Cytogénétique Hématologique (GFCH)
Pathol Biol (Paris); 2004 Jun; 52(5):245-7. PubMed ID: 15217704
[No Abstract] [Full Text] [Related]
35. [Introduction to recommendations for the cytogenetic management of hematopoietic diseases].
Dastugue N;
Pathol Biol (Paris); 2004 Jun; 52(5):235-7. PubMed ID: 15217701
[No Abstract] [Full Text] [Related]
36. [Essentials of conventional and molecular cytogenetics: application to diagnosis of hematological malignancies].
Lafage-Pochitaloff M
Pathol Biol (Paris); 2003 Aug; 51(6):307-11. PubMed ID: 12927887
[No Abstract] [Full Text] [Related]
37. [Recommendations for the cytogenetic management of acute myeloblastic leukemia established by the French Group for Cytogenetic Hematology].
Groupe Français de Cytogénétique Hématologique (GFCH)
Pathol Biol (Paris); 2004 Jun; 52(5):248-50. PubMed ID: 15217705
[No Abstract] [Full Text] [Related]
38. [Recommendations for the cytogenetic management of myeloproliferative syndromes proposed by the French Group for Cytogenetic Hematology].
Groupe Français de Cytogénétique Hématologique (GFCH)
Pathol Biol (Paris); 2004 Jun; 52(5):241-4. PubMed ID: 15217703
[No Abstract] [Full Text] [Related]
39. [Recommendations for performing cytogenetic studies in hematological malignancies].
Solé F; Espinet B; Woessner S
Sangre (Barc); 1999 Feb; 44(1):73-5. PubMed ID: 10323101
[No Abstract] [Full Text] [Related]
40. Diagnostic application of FISH to hematological malignancies.
Najfeld V
Cancer Invest; 2003; 21(5):807-14. PubMed ID: 14628438
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
